Back to search

Article

Characterizing the thrombotic spectrum and clinical phenotypes of tranexamic acid-associated adverse events: a pharmacovigilance study based on the FAERS database

2026-07-22

Abstract excerpt

<title>Abstract</title> <p>Tranexamic acid (TXA) is widely used to reduce bleeding in surgical, trauma, obstetric, and gynecological settings. However, concerns remain regarding TXA-associated thrombotic adverse events, and their phenotypic heterogeneity and clinical severity have not been comprehensively characterized. This study investigated TXA-associated thrombotic events using the Food and Drug Administratio...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d16bb5c5-bb65-5c1e-b197-30f29b765ada
DOI
10.21203/rs.3.rs-10337481/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Characterizing the thrombotic spectrum and clinical phenotypes of tranexamic acid-associated adverse events: a pharmacovigilance study based on the FAERS databaseDOI 10.21203/rs.3.rs-10337481/v1
INCIDENCE OF VENOUS THROMBOTIC EVENTS AND EVENTS OF SPECIAL INTEREST IN A RETROSPECTIVE COHORT OF COMMERCIALLY-INSURED US PATIENTSSemantic proximity
A disproportionate analysis of novel oral anticoagulants in the overall and pediatric populations: a pharmacovigilance study based on FDA Adverse Event Reporting System databaseSemantic proximity
Safety profile of rivaroxaban in first-time users treated for venous thromboembolism (deep vein thrombosis and pulmonary embolism) in four European countriesSemantic proximity
Real-World Data Analysis of Vascular and Lymphatic Adverse Events Associated with Anti-Tumor Angiogenesis Drugs: A WHO-VigiAccess StudySemantic proximity
The Efficacy and Safety of Tranexamic Acid Combined with Rivaroxaban in Prevention of Clinical Events in Patients after Total Knee/ Hip Arthroplasty: A Meta-analysisSemantic proximity
Statistical analysis plan for the WOMAN-ETAPlaT study: Effect of tranexamic acid on platelet function and thrombin generationSemantic proximity
The risk profiles of pregnancy-related intracranial venous thrombosis: a retrospective study in a comprehensive hospitalSemantic proximity
A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for TivozanibSemantic proximity
Signal Mining for Non-Bleeding Adverse Event in Novel Oral Anticoagulants: A Pharmacovigilance Study Based on the FAERS DatabaseSemantic proximity
Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID-19 vaccine safety surveillance: incidence between 2017 and 2019 and patient profiles from 25.4 million people in six European countriesSemantic proximity
Characteristics and Risk Factors of Low-Molecular-Weight Heparin–Related Medication Errors: Analysis of 129 Medical Malpractice Litigation CasesSemantic proximity
Management of antithrombotic agents during emergency endoscopy for upper gastrointestinal bleeding: A propensity score matching analysisSemantic proximity
Select a neighboring publication to make it the new centre.